It impacts parts of the brain that manage hunger and how full we feel
GLP-1 agonists are medications that mimic the effects of the GLP-1 hormone, which is produced in the intestines
The primary evidence-based treatment for fatty liver disease is lifestyle modification, including weight loss of at least 710% through dietary changes and increased physical activity
Real-world reviews highlight Ros ease of use, especially when it comes to communication, medication access, and provider responsiveness
Its lead candidate, pemvidutide, is being evaluated in multiple indications, including metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder, and alcohol-associated liver disease